Trials / Completed
CompletedNCT02162121
Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- ASST Gaetano Pini-CTO · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Stimulating catheters have been introduced to reduce the incidence of secondary failure after continuous peripheral nerve blocks, but they effectiveness over traditional nonstimulating catheters is still controversial. The aim of this prospective, randomized, blinded study is to detect if stimulating catheters improve postoperative compared with conventional non-stimulating catheters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Continuous lumbar plexus: stimulating catheter | Perinervous stimulating catheter ("Stimulong", "Pajunk", Germany) will be insert in lumbar plexus through tuohy needle (18G, 100mm length). 15ml mepivacaine 1% are injected before the complete resolution of the spinal anesthesia. |
| PROCEDURE | Spinal Anesthesia | Spinal anesthesia will be perform at L3-L4 or L4-L5 level. Levobupivacaine 0,5% 15mg will be injected. |
| PROCEDURE | Local anesthetic infusion | Continuous infusion (Mini Rythmic Evolution, Micrel) of ropivacaine 0,2% at 3ml/h, bolus 3 ml, lockout time 15 min, 12 ml/h maximum dose through perinervous catheter until 3rd postoperative day |
| PROCEDURE | Intravenous analgesia | Ketorolac 30mg 3 times a day |
| PROCEDURE | Opioids rescue analgesia | Buprenorphine 0,2mg twice a day if VAS\>4 |
| DRUG | Mepivacaine 1% | |
| DRUG | Levobupivacaine 0,5% | |
| DRUG | Ropivacaine 0,2% | |
| DRUG | Ketorolac 30mg | |
| DRUG | Buprenorphine 0,2mg | |
| DEVICE | Stimulong, Pajunk, Germany. | |
| PROCEDURE | Continuous lumbar plexus: non-stimulating catheter |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2014-06-12
- Last updated
- 2017-08-14
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02162121. Inclusion in this directory is not an endorsement.